{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:39:24Z","timestamp":1770989964283,"version":"3.50.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144475","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T19:15:07Z","timestamp":1449602107000},"page":"e0144475","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases"],"prefix":"10.1371","volume":"10","author":[{"given":"Jiandong","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meini","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningzhu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"issue":"40","key":"ref1","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.2807\/ese.17.40.20290-en","article-title":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012","volume":"17","author":"A Bermingham","year":"2012","journal-title":"Euro Surveill"},{"issue":"19","key":"ref2","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"AM Zaki","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/JVI.03488-13","article-title":"Coronaviruses: important emerging human pathogens","volume":"88","author":"CM Coleman","year":"2014","journal-title":"J Virol"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3201\/eid1910.130946","article-title":"Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa","volume":"19","author":"NL Ithete","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"e01146","DOI":"10.1128\/mBio.01146-14","article-title":"Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia","volume":"5","author":"T Briese","year":"2014","journal-title":"MBio"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virusres.2015.01.021","article-title":"Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd","volume":"202","author":"IM Mackay","year":"2015","journal-title":"Virus Res"},{"issue":"9997","key":"ref7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"A Zumla","year":"2015","journal-title":"Lancet"},{"key":"ref8","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERSCoV)\u2013Republic of Korea. 26 June 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/csr\/don\/26-june-2015-mers-korea\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/csr\/don\/26-june-2015-mers-korea\/en\/<\/ext-link>. Accessed 2015 Jul 16."},{"issue":"21","key":"ref9","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"F Song","year":"2013","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"L Wang","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus","volume":"145","author":"X Guo","year":"2015","journal-title":"Immunology"},{"issue":"17","key":"ref12","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"L Du","year":"2013","journal-title":"J Virol"},{"issue":"45","key":"ref13","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"E Kim","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus","volume":"11","author":"J Tang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"ref15","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein","volume":"89","author":"A Volz","year":"2015","journal-title":"J Virol"},{"issue":"16","key":"ref16","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"H Mou","year":"2013","journal-title":"J Virol"},{"issue":"17","key":"ref17","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"L Du","year":"2013","journal-title":"J Virol"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"L Du","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"N Zhang","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"e00650","DOI":"10.1128\/mBio.00650-13","article-title":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate","volume":"4","author":"F Almaz\u00e1n","year":"2013","journal-title":"MBio"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"AW Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"20","key":"ref22","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1016\/j.vaccine.2006.03.009","article-title":"Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects","volume":"24","author":"C Firbas","year":"2006","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1743-422X-7-351","article-title":"Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development","volume":"7","author":"Z Stanekov\u00e1","year":"2010","journal-title":"Virol J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1038\/srep12501","article-title":"Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding","volume":"5","author":"L He","year":"2015","journal-title":"Sci Rep"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1128\/CVI.00468-09","article-title":"Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes","volume":"17","author":"I Sominskaya","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/14760584.2015.955478","article-title":"Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases","volume":"14","author":"FE Terry","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"IA Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref28","first-page":"531","article-title":"Protein identification and analysis tools in the ExPASy server","volume":"112","author":"MR Wilkins","year":"1999","journal-title":"Methods Mol Biol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0968-0004(99)01540-6","article-title":"NPS@: network protein sequence analysis","volume":"25","author":"C Combet","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-0366-5_2","article-title":"RaptorX server: a resource for template-based protein structure modeling","volume":"1137","author":"M K\u00e4llberg","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"AS Kolaskar","year":"1990","journal-title":"FEBS Lett"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/prot.340190207","article-title":"Accuracy of protein flexibility predictions","volume":"19","author":"M Vihinen","year":"1994","journal-title":"Proteins"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/JVI.55.3.836-839.1985","article-title":"Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide","volume":"55","author":"EA Emini","year":"1985","journal-title":"J Virol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"JA Wilson","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00251-013-0720-y","article-title":"NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ","volume":"65","author":"E Karosiene","year":"2013","journal-title":"Immunogenetics"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/bib\/bbr060","article-title":"Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools","volume":"13","author":"L Zhang","year":"2012","journal-title":"Brief Bioinform"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","article-title":"NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence","volume":"2","author":"M Nielsen","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","article-title":"NetMHCpan, a method for MHC class I binding prediction beyond humans","volume":"61","author":"I Hoof","year":"2009","journal-title":"Immunogenetics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"W525","DOI":"10.1093\/nar\/gks438","article-title":"Immune epitope database analysis resource","volume":"40","author":"Y Kim","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T-cell epitopes using neural networks with novel sequence representations","volume":"12","author":"M Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8\u201311","volume":"36","author":"C Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2105-6-132","article-title":"Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method","volume":"6","author":"B Peters","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-4-2","article-title":"Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries","volume":"4","author":"J Sidney","year":"2008","journal-title":"Immunome Res"},{"issue":"10","key":"ref44","doi-asserted-by":"crossref","first-page":"e1003266","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"JJ Calis","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/1471-2105-8-361","article-title":"Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines","volume":"8","author":"HH Bui","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"e5861","DOI":"10.1371\/journal.pone.0005861","article-title":"AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins","volume":"4","author":"HC Muh","year":"2009","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"HH Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"16","key":"ref48","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1111\/j.1742-4658.2007.05947.x","article-title":"Expression, post-translational modification and biochemical characterization of proteins encoded by subgenomic mRNA8 of the severe acute respiratory syndrome coronavirus","volume":"274","author":"TM Le","year":"2007","journal-title":"FEBS J"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"N Wang","year":"2013","journal-title":"Cell Res"},{"issue":"36","key":"ref50","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1016\/j.vaccine.2009.05.073","article-title":"Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice","volume":"27","author":"N Zheng","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"ref51","first-page":"459","article-title":"Comparative immunization in BALB\/c mice with recombinant replication-defective adenovirus vector and DNA plasmid expressing a SARS-CoV nucleocapsid protein gene","volume":"3","author":"C Ma","year":"2006","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10529-009-0061-y","article-title":"Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice","volume":"31","author":"H Hu","year":"2009","journal-title":"Biotechnol Lett"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2008.03.003","article-title":"Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine","volume":"118","author":"NK Dutta","year":"2008","journal-title":"Immunol Lett"},{"issue":"16","key":"ref54","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.vaccine.2006.01.058","article-title":"Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates","volume":"24","author":"SJ Liu","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1128\/JVI.02568-06","article-title":"Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus","volume":"81","author":"J Zhao","year":"2007","journal-title":"J Virol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.177.4.2138","article-title":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes","volume":"177","author":"M Zhou","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.virusres.2012.10.028","article-title":"Fine level epitope mapping and conservation analysis of two novel linear B-cell epitopes of the avian infectious bronchitis coronavirus nucleocapsid protein","volume":"171","author":"Z Han","year":"2013","journal-title":"Virus Res"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virol.2005.11.042","article-title":"SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens","volume":"347","author":"V Gupta","year":"2006","journal-title":"Virology"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00253-011-3734-0","article-title":"High-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein","volume":"93","author":"DQ Liu","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"ref60","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"JA Wilson","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jinf.2015.07.002","article-title":"Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection","volume":"71","author":"X Gao","year":"2015","journal-title":"J Infect"},{"issue":"5\u20136","key":"ref62","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","article-title":"Memory T cells and vaccines","volume":"21","author":"MT Esser","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0959-440X(99)00039-1","article-title":"MHC superfamily structure and the immune system","volume":"9","author":"K Maenaka","year":"1999","journal-title":"Curr Opin Struct Biol"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0969-2126(00)00026-5","article-title":"Antigenic peptide binding by class I and class II histocompatibility proteins","volume":"2","author":"LJ Stern","year":"1994","journal-title":"Structure"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T14:55:07Z","timestamp":1653749707000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144475"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144475","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}